these arrhythmias can cause a blood clot to form in the heart. This can lead to a stroke or a blockage carried by the blood flow (an embolism ) anywhere in the body's arteries. Atrial fibrillation is responsible for about 15% of strokes
Patients with atrial fibrillation and flutter can live a normal life for many years as long as the arrhythmia is controlled and serious blood clots are prevented
They're he same thing. Atrial flutter is more of a slang term, and is sometimes found in patients with atrial tachycardia. Basically, atrial fibrillation is a disorder, and atrial flutter is a symptom
Ventricular fibrillation, since this pumps blood to the rest of the body.
Atrial Flutter. You may be thinking of atrial fibrillation, though.
Most often, cardioversion is used to treat atrial fibrillation or atrial flutter. Life-saving cardioversion can be used to treat ventricular tachycardia and ventricular fibrillation.
abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles, or lower chambers of the heart. In atrial fibrillation, the atria "quiver" chaotically and the ventricles beat irregularly
If patients with atrial fibrillation experience rapid heart rate (rapid ventricular response) and are hemodynamically unstable (hypotension, altered mental status) then electrical cardioversion is appropriate. Defibrillation is never utilized in atrial fibrillation.
To prevent blood clots, aspirin or warfarin (Coumadin) is administered. Warfarin, however, has potential bleeding side effects, especially in older patients
Defibrillation is performed to correct life-threatening arrhythmias of the heart including ventricular fibrillation and cardiac arrest.in non-life threatening situations, atrial defibrillation can be used to treat atrial fibrillation or flutter.
The goal for patients who have atrial fibrillation are for their heart rates to be normal (60-80).
Azimilide is currently being evaluated for its use in atrial fibrillation, atrial flutter, and PSVT. Additionally there were phase III trials being conducted for ventricular tachyarrhythmias and in patients with ICDs. The drug has not yet been approved by the FDA and thus has no labeled indications at this time.
An atrial fibrillation is a cardiac arrhythmia which involves the upper two chambers of the heart.
The symptoms are variable for people, but most of the patients with atrial flutter describe having a rapid heartbeat, a fluttering feeling in the chest, shortness of breath, anxiety and weakness. This does not count for people with heart or lung diseases.